Published Online
on May 2, 2005

A more recent version of this article appeared on May 10, 2005

This Article Full Text (PDF) All Versions of this Article: 111/18/2330    most recent 01.CIR.0000164234.24957.75v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sanbe, A. Articles by Robbins, J. Search for Related Content PubMed PubMed Citation Articles by Sanbe, A. Articles by Robbins, J. Related Collections Contractile function Animal models of human disease Related Article

Submitted on August 2, 2004
Revised on December 29, 2004
Accepted on January 4, 2005

Transgenic Rabbit Model for Human Troponin I-Based Hypertrophic Cardiomyopathy

Atsushi Sanbe PhD, Jeanne James MD, Volkan Tuzcu MD, Selman Nas PhD, Lisa Martin AS, James Gulick MS, Hanna Osinska PhD, Sadayappan Sakthivel PhD, Raisa Klevitsky PhD, Kenneth S. Ginsburg PhD, Donald M. Bers PhD, Bruce Zinman MS, Edward G. Lakatta MD, and Jeffrey Robbins PhD^*

From the Divisions of Molecular Cardiovascular Biology (A.S., J.J., L.M., J.G., H.O., S.S., R.K., J.R.) and Pediatric Cardiology (V.T., S.N.), Cincinnati Children’s Hospital Research Foundation, Cincinnati, Ohio; Loyola University Chicago, Department of Physiology and Cardiovascular Institute, Maywood, Ill (K.S.G., D.M.B.); and National Institute on Aging, Intramural Research Program, Gerontology Research Center, National Institutes of Health, Baltimore, Md (B.Z., E.G.L.).

^* To whom correspondence should be addressed. E-mail: jeff.robbins{at}cchmc.org.

Background--Transgenic and gene-targeted models have focused on the mouse. Fundamental differences between the mouse and human exist in Ca²⁺ handling during contraction/relaxation and in alterations in Ca²⁺ flux during heart failure, with the rabbit more accurately reflecting the human system.

Methods and Results--Cardiac troponin I (cTnI) mutations can cause familial hypertrophic cardiomyopathy. An inhibitory domain mutation, arginine146glycine (cTnI^146Gly), was modeled with the use of transgenic expression in the rabbit ventricle. cTnI^146Gly levels >40% of total cTnI were perinatally lethal, whereas replacement levels of 15% to 25% were well tolerated. cTnI^146Gly expression led to a leftward shift in the force-pCa²⁺ curves with cardiomyocyte disarray, fibrosis, and altered connexin43 organization. In isolated cTnI^146Gly myocytes, twitch relaxation amplitudes were smaller than in normal cells, but [Ca]_i transients and sarcoplasmic reticulum Ca²⁺ load were not different. Detrended fluctuation analysis of the QT_max intervals was used to evaluate the cardiac repolarization phase and showed a significantly higher scaling exponent in the transgenic animals.

Conclusions--Expression of modest amounts of cTnI^146Gly led to subtle defects without severely affecting cardiac function. Aberrant connexin organization, subtle morphological deficits, and an altered fractal pattern of the repolarization phase of transgenic rabbits, in the absence of entropy or other ECG abnormalities, may indicate an early developing pathology before the onset of more obvious repolarization abnormalities or major alterations in cardiac mechanics.

Key words: cardiovascular diseases • heart diseases • hypertrophy

Related Article:

On Mice, Rabbits, and Human Heart Failure

A.J. Marian
Circulation 2005 111: 2276-2279. [Extract] [Full Text]

This article has been cited by other articles:

				J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF]

				Y. Wen, J. R. Pinto, A. V. Gomes, Y. Xu, Y. Wang, Y. Wang, J. D. Potter, and W. G. L. Kerrick Functional Consequences of the Human Cardiac Troponin I Hypertrophic Cardiomyopathy Mutation R145G in Transgenic Mice J. Biol. Chem., July 18, 2008; 283(29): 20484 - 20494. [Abstract] [Full Text] [PDF]

				J. Du, J. Liu, H.-Z. Feng, M. M. Hossain, N. Gobara, C. Zhang, Y. Li, P.-Y. Jean-Charles, J.-P. Jin, and X.-P. Huang Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2604 - H2613. [Abstract] [Full Text] [PDF]

				T. Tsoutsman, M. Kelly, D. C.H. Ng, J.-E. Tan, E. Tu, L. Lam, M. A. Bogoyevitch, C. E. Seidman, J.G. Seidman, and C. Semsarian Severe Heart Failure and Early Mortality in a Double-Mutation Mouse Model of Familial Hypertrophic Cardiomyopathy Circulation, April 8, 2008; 117(14): 1820 - 1831. [Abstract] [Full Text] [PDF]

				S. Sadayappan, N. Finley, J. W. Howarth, H. Osinska, R. Klevitsky, J. N. Lorenz, P. R. Rosevear, and J. Robbins Role of the acidic N' region of cardiac troponin I in regulating myocardial function FASEB J, April 1, 2008; 22(4): 1246 - 1257. [Abstract] [Full Text] [PDF]

				C. M. Ripplinger, W. Li, J. Hadley, J. Chen, F. Rothenberg, R. Lombardi, S. A. Wickline, A. J. Marian, and I. R. Efimov Enhanced Transmural Fiber Rotation and Connexin 43 Heterogeneity Are Associated With an Increased Upper Limit of Vulnerability in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy Circ. Res., November 9, 2007; 101(10): 1049 - 1057. [Abstract] [Full Text] [PDF]

				J. Liu, J. Du, C. Zhang, J. W. Walker, and X. Huang Progressive troponin I loss impairs cardiac relaxation and causes heart failure in mice Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1273 - H1281. [Abstract] [Full Text] [PDF]

				W. Liu, M. W. Ashford, J. Chen, M. P. Watkins, T. A. Williams, S. A. Wickline, and X. Yu MR tagging demonstrates quantitative differences in regional ventricular wall motion in mice, rats, and men Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2515 - H2521. [Abstract] [Full Text] [PDF]

				A.J. Marian On Mice, Rabbits, and Human Heart Failure Circulation, May 10, 2005; 111(18): 2276 - 2279. [Full Text] [PDF]

				J. James, L. Martin, M. Krenz, C. Quatman, F. Jones, R. Klevitsky, J. Gulick, and J. Robbins Forced Expression of {alpha}-Myosin Heavy Chain in the Rabbit Ventricle Results in Cardioprotection Under Cardiomyopathic Conditions Circulation, May 10, 2005; 111(18): 2339 - 2346. [Abstract] [Full Text] [PDF]